ICH GCP Annex 2 will strengthen sponsor confidence in the use of DCTs and RWD

RegulatoryPositive

AI Analysis

Summary

ICH GCP Annex 2 guidance aims to strengthen sponsor confidence in decentralised clinical trials and real-world data through global regulatory harmonisation. The article discusses increasing adoption of new clinical trial models but lacks specific company, drug, or outcome information.

Importance:3/10

Sentiment:

0.30

ICH GCP Annex 2decentralised trialsDCTsreal-world dataRWDregulatory harmonisationclinical trial models

Read the original article

Published by Clinical Trials Arena on August 17, 2026 7:59 AM

Read Original